Publication Name	World Journal of Diabetes
Manuscript ID	88737
Country	China

Received	2023-10-08 01:46
Peer-Review Started	2023-10-08 01:48
To Make the First Decision
Return for Revision	2023-12-18 23:57
Revised	2023-12-31 05:48
Second Decision	2024-02-14 02:09
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-03-25 05:43
Articles in Press	2024-03-25 05:43
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-02-08 11:52
Typeset the Manuscript	2024-04-23 09:49
Publish the Manuscript Online	2024-05-10 11:51

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Minireviews
Article Title	Role of angiotensin receptor-neprilysin inhibitor in diabetic complications
Manuscript Source	Invited Manuscript
All Author List	Ying Liu, Cun-Yu Lu, Yi Zheng, Yu-Min Zhang, Ling-Ling Qian, Ku-Lin Li, Gary Tse, Ru-Xing Wang and Tong Liu
Funding Agency and Grant Number	Funding Agency Grant Number Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-029A National Natural Science Foundation of China 82370342
Corresponding Author	Tong Liu, PhD, Professor, Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Hexi District, Tianjin 300211, China. liutongdoc@126.com
Key Words	Angiotensin receptor-neprilysin inhibitor; Diabetic mellitus; Complication
Core Tip	Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angiotensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.
Publish Date	2024-05-10 11:51
Citation	Liu Y, Lu CY, Zheng Y, Zhang YM, Qian LL, Li KL, Tse G, Wang RX, Liu T. Role of angiotensin receptor-neprilysin inhibitor in diabetic complications. World J Diabetes 2024; 15(5): 867-875
URL	https://www.wjgnet.com/1948-9358/full/v15/i5/867.htm
DOI	10.4239/wjd.v15.i5.867

Full Article (PDF)	WJD-15-867-with-cover.pdf
Full Article (Word)	WJD-15-867.docx
Manuscript File	88737_Auto_Edited-JJW-Webster J-YJP.docx
Answering Reviewers	88737-Answering reviewers.pdf
Audio Core Tip	88737-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	88737-Conflict-of-interest statement.pdf
Copyright License Agreement	88737-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	88737-Grant application form(s).pdf
Peer-review Report	88737-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	88737-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	88737-Bing-Wang JJ-2.png
Scientific Editor Work List	88737-Scientific editor work list.pdf
CrossCheck Report	88737-CrossCheck report.pdf